MX387128B - Métodos para la síntesis de esfingomielinas y dihidroesfingomielinas. - Google Patents

Métodos para la síntesis de esfingomielinas y dihidroesfingomielinas.

Info

Publication number
MX387128B
MX387128B MX2015012877A MX2015012877A MX387128B MX 387128 B MX387128 B MX 387128B MX 2015012877 A MX2015012877 A MX 2015012877A MX 2015012877 A MX2015012877 A MX 2015012877A MX 387128 B MX387128 B MX 387128B
Authority
MX
Mexico
Prior art keywords
synthesis
sphingomyelins
methods
dihydroesphingomyelins
present
Prior art date
Application number
MX2015012877A
Other languages
English (en)
Spanish (es)
Other versions
MX2015012877A (es
Inventor
Andreas Peer
Benoit Oswald
Daniela Carmen Oniciu
Miguel Gonzalez
Patrik Sauter
Peter Rebmann
Stefan Heckhoff
Original Assignee
Cerenis Therapeutics Holding Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerenis Therapeutics Holding Sa filed Critical Cerenis Therapeutics Holding Sa
Publication of MX2015012877A publication Critical patent/MX2015012877A/es
Publication of MX387128B publication Critical patent/MX387128B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/141Esters of phosphorous acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/24Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and acyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/10Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/02Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of compounds containing imino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/113Esters of phosphoric acids with unsaturated acyclic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MX2015012877A 2013-03-15 2014-03-14 Métodos para la síntesis de esfingomielinas y dihidroesfingomielinas. MX387128B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361801641P 2013-03-15 2013-03-15
EP13306056 2013-07-23
PCT/IB2014/000494 WO2014140787A2 (en) 2013-03-15 2014-03-14 Methods for the synthesis of sphingomyelins and dihydrosphingomyelins

Publications (2)

Publication Number Publication Date
MX2015012877A MX2015012877A (es) 2016-02-03
MX387128B true MX387128B (es) 2025-03-19

Family

ID=51538203

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015012877A MX387128B (es) 2013-03-15 2014-03-14 Métodos para la síntesis de esfingomielinas y dihidroesfingomielinas.

Country Status (16)

Country Link
US (3) US20140316154A1 (OSRAM)
EP (3) EP3363805B1 (OSRAM)
JP (2) JP6438417B2 (OSRAM)
KR (1) KR20150132188A (OSRAM)
CN (1) CN105051051B (OSRAM)
AU (2) AU2014229638B2 (OSRAM)
BR (1) BR112015023558A2 (OSRAM)
CA (1) CA2900902C (OSRAM)
DK (1) DK3363805T3 (OSRAM)
ES (1) ES3017659T3 (OSRAM)
HK (1) HK1214266A1 (OSRAM)
MX (1) MX387128B (OSRAM)
PH (1) PH12015501835B1 (OSRAM)
SG (2) SG10201804887YA (OSRAM)
WO (1) WO2014140787A2 (OSRAM)
ZA (1) ZA201505860B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201700203T1 (it) 2009-02-16 2017-05-08 Cerenis Therapeutics Holding Sa Mimetici di apolipoproteina a-i
SG2014012850A (en) 2010-10-18 2014-05-29 Cerenis Therapeutics Holding Sa Compounds, compositions and methods useful for cholesterol mobilisation
JP6438417B2 (ja) * 2013-03-15 2018-12-12 セレニス セラピューティクス ホールディング エスアー スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
WO2019030574A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding Cargomers
WO2019030575A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding APOMÈRES
EP3778611B1 (en) * 2018-03-27 2022-10-12 NOF Corporation Sphingomyelin-derived lipid and method for producing same
JP7303618B2 (ja) * 2018-10-05 2023-07-05 日本精化株式会社 スフィンゴリン脂質前駆体及びその製造方法、並びに、スフィンゴリン脂質の製造方法
WO2021209808A1 (en) 2020-04-16 2021-10-21 Abionyx Pharma Sa Cer-001 therapy for treating kidney disease
IL297046A (en) 2020-04-16 2022-12-01 Abionyx Pharma Sa Treatment of kidney disease using cer-001
CN115427064A (zh) 2020-04-16 2022-12-02 阿比奥尼克斯制药公司 使用基于脂质结合蛋白的复合物治疗急性病况的方法
EP4221686A2 (en) 2020-10-01 2023-08-09 Abionyx Pharma SA Compositions comprising lipid binding protein-based complexes for use for treating eye diseases
JP2024514154A (ja) 2021-04-15 2024-03-28 アビオニクス ファーマ エスエー 臓器保存溶液における脂質結合タンパク質ベースの複合体の使用
CA3247588A1 (en) 2022-04-06 2023-10-12 Abionyx Pharma Sa METHODS FOR TREATING LEUKOCYTOSIS, ENDOTHELIAL DYSFUNCTION AND CARDITIS USING LIPID-BINDING PROTEIN COMPLEXES
AU2023250345A1 (en) 2022-04-06 2024-11-14 Abionyx Pharma Sa Methods for treating eye diseases using lipid binding protein-based complexes
WO2023237927A2 (en) 2022-06-10 2023-12-14 Abionyx Pharma Sa Methods for treating hyperinflammatory conditions using lipid binding protein -based complexes
AU2023284357A1 (en) 2022-06-10 2025-01-23 Abionyx Pharma Sa Methods for treating acute conditions using lipid binding protein-based complexes
KR20250035547A (ko) 2022-06-28 2025-03-12 아비오닉스 파마 에스에이 스핑고미엘린의 합성을 위한 화합물 및 공정
IL322074A (en) 2023-01-13 2025-09-01 Abionyx Pharma Sa Treatment using a lipid-binding protein molecule
WO2025093929A1 (en) 2023-10-31 2025-05-08 Abionyx Pharma Sa Lipid binding protein molecule therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146810A3 (de) 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US5220043A (en) * 1991-03-21 1993-06-15 Ohio University Synthesis of D-erythro-sphingomyelins
CN1099868C (zh) 1993-11-16 2003-01-29 斯卡法玛公司 具有控制释放活性成分作用的囊
US5766627A (en) 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
CA2320117A1 (en) * 1998-02-12 1999-08-19 Emory University Sphingolipid derivatives and their methods of use
JP2004002215A (ja) * 2002-05-23 2004-01-08 National Institute Of Advanced Industrial & Technology スフィンゴ脂質誘導体の製造方法
EP1704155A1 (en) 2004-01-15 2006-09-27 Biolab Ltd. Sphingomyelin, intermediates thereof and methods for preparation of same
CA2566559C (en) 2004-05-17 2014-05-06 Inex Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
CA2572310A1 (en) * 2004-06-29 2006-01-12 Jadolabs Gmbh Sphingolipid-derived pharmaceutical compositions
JP2006045113A (ja) 2004-08-04 2006-02-16 Kemikurea:Kk リン酸エステル類
JP4825947B2 (ja) 2004-08-04 2011-11-30 学校法人関西学院 不飽和アミノジオール類の製造方法
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
AR057456A1 (es) 2005-07-20 2007-12-05 Merck & Co Inc Inhibidores de la proteasa ns3 del vhc
JP2007204384A (ja) 2006-01-31 2007-08-16 Kemikurea:Kk 光学活性リン酸誘導体およびこれを用いた光学活性スフィンゴシン1−リン酸誘導体の製造方法
JP5429734B2 (ja) * 2007-02-09 2014-02-26 国立大学法人岐阜大学 スフィンゴ糖脂質の合成法
JP5178707B2 (ja) 2007-03-09 2013-04-10 株式会社糖鎖工学研究所 スフィンゴシン化合物、その製造方法及びスフィンゴミエリナーゼ阻害剤
CN102223878A (zh) 2008-10-07 2011-10-19 耶路撒冷希伯来大学伊森姆研究发展公司 包含鞘磷脂的脂质体系统
HUE042314T2 (hu) 2011-02-07 2019-06-28 Cerenis Therapeutics Holding Sa Lipoprotein komplexek és azok gyártása és alkalmazásai
FR3000959B1 (fr) * 2013-01-14 2015-08-21 Holis Technologies Nouveaux intermediaires de synthese permettant d'acceder avec de bons rendements a des derives de sphingosines, ceramides et sphingomyelines
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
JP6438417B2 (ja) 2013-03-15 2018-12-12 セレニス セラピューティクス ホールディング エスアー スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Also Published As

Publication number Publication date
HK1214266A1 (zh) 2016-07-22
PH12015501835A1 (en) 2015-11-09
CA2900902A1 (en) 2014-09-18
MX2015012877A (es) 2016-02-03
EP3842443C0 (en) 2025-02-19
WO2014140787A2 (en) 2014-09-18
JP6438417B2 (ja) 2018-12-12
JP2016511281A (ja) 2016-04-14
US20140316154A1 (en) 2014-10-23
WO2014140787A3 (en) 2015-03-26
AU2014229638A1 (en) 2015-08-20
BR112015023558A2 (pt) 2017-07-18
EP3842443B1 (en) 2025-02-19
US20170204122A1 (en) 2017-07-20
HK1212705A1 (zh) 2016-06-17
CN105051051B (zh) 2021-07-16
SG10201804887YA (en) 2018-07-30
CA2900902C (en) 2022-08-02
EP3363805A1 (en) 2018-08-22
EP3842443A1 (en) 2021-06-30
SG11201506456VA (en) 2015-09-29
AU2018267598A1 (en) 2018-12-06
CN105051051A (zh) 2015-11-11
KR20150132188A (ko) 2015-11-25
ES3017659T3 (en) 2025-05-13
PH12015501835B1 (en) 2015-11-09
US20160075634A1 (en) 2016-03-17
DK3363805T3 (da) 2021-03-08
JP2018168171A (ja) 2018-11-01
EP3363805B1 (en) 2020-12-16
EP2970344A2 (en) 2016-01-20
AU2014229638B2 (en) 2018-09-06
US9643915B2 (en) 2017-05-09
ZA201505860B (en) 2017-11-29

Similar Documents

Publication Publication Date Title
MX387128B (es) Métodos para la síntesis de esfingomielinas y dihidroesfingomielinas.
CL2015002742A1 (es) Moléculas de unión para bcma y cd3.
ZA201707967B (en) Antibody constructs for cd70 and cd3
CL2016000460A1 (es) Proteínas de unión al antígeno gitr
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
CR20150046A (es) Anticuerpos anti-cd79b e inmunoconjugados
MX2015012326A (es) Anticuerpos anti-crth2 y su uso.
CR20150482A (es) Anticuerpos e inmunoconjugados anti-b7-h4
CR20150049A (es) Anticuerpos e inmunoconjugados anti-cd79b
CL2016001432A1 (es) Nuevos anticuerpos anti-dpep3 y métodos de uso
MX2015013901A (es) Anticuerpos anti-il-4 y anticuerpos biespecificos y sus usos.
MX2015017341A (es) Anticuerpos anti-factor del complemento c1q y uso de los mismos.
IN2014DN05885A (OSRAM)
EP2859350A4 (en) USE OF 5-ALA FOR DETECTION OF CEREBRAL TUMORS
IN2013MU00848A (OSRAM)
AR097668A1 (es) Colorante-polímero
MX2014014381A (es) Anticuerpos de anti-teofilina y metodos de uso.
ZA201603457B (en) Novel method for the synthesis of agomelatine
PH12016501201A1 (en) Synthesis of ent-progesterone and intermediates thereof
EP3684647A4 (en) SUB-INSTRUMENT PANEL EMERGENCY VISION DEVICE
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
PH12018500508A1 (en) Methods for the synthesis of spingomyelins and dihydrosphingomyelins
BR112018007282A2 (pt) métodos para síntese total de resolvina e1
MX2015010789A (es) Anticuerpos anti-pcsm.
DE112014003192A5 (de) Verfahren zur Biosynthese von spezifisch isotopenmarkierten Sekundärmetaboliten